menu
    • menu

    Company profile for Piramal Critical Care

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Piramal Critical Care is a global critical care company focused on saving lives with critical care solutions and the ability to build successful partnerships has always been an integral part of our growth story. Since the inception of Piramal Group more than two decades ago, we have formed upwards of 40 different business relationships with pharmaceutical companies both large and small in various geographies and across a range...
    Piramal Critical Care is a global critical care company focused on saving lives with critical care solutions and the ability to build successful partnerships has always been an integral part of our growth story. Since the inception of Piramal Group more than two decades ago, we have formed upwards of 40 different business relationships with pharmaceutical companies both large and small in various geographies and across a range of therapeutic areas including anesthesia, CNS, and pain. Piramal Critical Care marked its entry in the field of inhalation anesthetics in 2002 with the acquisition of ICI India Ltd.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Piramal Critical CareUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3950 Schelden Circle Bethlehem, PA 18017
    Telephone
    Telephone
    +1-800-414-1901
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://piramalcriticalcare.us/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BrePco, Piramal Get MHRA Approval For Neoatricon In UK
    BrePco, Piramal Get MHRA Approval For Neoatricon In UK

    21 Mar 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/drug-approval/brepco-biopharma-and-piramal-critical-care-announce-mhra-approval-for-neoatricon-in-uk-16924

    INDPHARMAPOST
    21 Mar 2025
    Share Share
    Piramal Launches Chlorpromazine Hydrochloride Injection In US
    Piramal Launches Chlorpromazine Hydrochloride Injection In US

    23 Jan 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/piramal-critical-care-launches-chlorpromazine-hydrochloride-for-injection-usp-in-the-us/

    EXPRESSPHARMA
    23 Jan 2025
    Share Share
    Piramal Critical's sugammadex Receives Approval in Europe
    Piramal Critical's sugammadex Receives Approval in Europe

    18 Jul 2023

    // EMA

    https://www.ema.europa.eu/en/documents/overview/sugammadex-piramal-epar-medicine-overview_en.pdf

    EMA
    18 Jul 2023
    Share Share
    Piramal Critical Appoints Jeffrey Hampton as President & Chief Operating Officer
    Piramal Critical Appoints Jeffrey Hampton as President & Chief Operating Officer

    06 Jun 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/piramal-critical-care-appoints-jeffrey-hampton-as-president--chief-operating-officer-301843488.html

    PR NEWSWIRE
    06 Jun 2023
    Share Share
    Piramal's Generic Dicyclomine Hydrochloride Receives Approval in the U.S.
    Piramal's Generic Dicyclomine Hydrochloride Receives Approval in the U.S.

    15 Dec 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215517

    FDA
    15 Dec 2022
    Share Share
    PCC commits to reduce its environmental footprint
    PCC commits to reduce its environmental footprint

    17 Nov 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/piramal-critical-care-pcc-commits-to-reduce-its-environmental-footprint-and-growing-responsibly-through-sustainable-operations-301681550.html

    PRNEWSWIRE
    17 Nov 2022
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search